Studies minimally invasive heat treatments for small thyroid cancers
Studies heat-based treatments as an alternative to surgery in adults with small thyroid cancer.
Plain-language title generated from the registry record
Registry title: Minimally Invasive Treatments of the Thyroid
Key facts
- Where
- Milan, ItalySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a small papillary thyroid cancer (microcarcinoma) proven by cell testing, who could be treated with a minimally invasive method instead of surgery.
- Age
- Older than 18 years (minimum age 18 Years).
- Sex
- All sexes can join.
- Disease stage
- Papillary thyroid microcarcinoma, proven by cell testing (cytology). The tumor must not be larger than 1 cm (0.4 in).
Main reasons for not taking part
- Tumor larger than 1 cm (0.4 in)
- Other cell type of thyroid tumor
- Refusing the minimally invasive treatment, or being unsuitable for it
- Blood clotting disorders that cannot be managed
- Psychiatric, addiction or other disorder that affects the ability to give informed consent
Read by machine on 12 November 2026.
Where in Italy
- European Institute of OncologyMilan, ItalyContact: Giovanni MauriTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- European Institute of Oncology
- Trial code
- NCT06333587
- Record updated
- 27 March 2024
- Original description
This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)Read full original descriptionShow less
Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma
This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)
Inclusion: Patients > 18years; Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT; Written informed consent must be signed and dated by the patient and the investigator prior to inclusion; Patients must be accessible for follow-up.
Exclusion: Tumors > 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders; Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study.